Virology Conferences | Virology Webinars | Corona Virus

Theme: An outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in Worldwide in the aspect of Virology

Euro Virology 2020

Conference Program

Renowned Speakers

Daniela Maria Cirillo
San Raffaele Scientific Institute Milan
Italy

Anand Ramasubramanian
University of Texas
USA

Dagmar Schoder
University of Veterinary Medicine
Austria

Palina Vyhouskaya
Jagiellonian University
Poland

Giovanni Matera
University of Catanzaro
Italy

Roby P. Bhattacharyya
Broad Institute of MIT and Harvard
USA

Giulio Filippo Tarro
Foundation de Beaumont Bonelli for Cancer Research
Italy

Sita Awasthi
University of Pennsylvania
USA

Juana DÃez
Pompeu Fabra University
Spain

Yuntao Wu
George Mason University
USA

Anil Kumar
University of Missouri
USA

Catherine H Schein
University of Texas
USA

Ulrich Desselberger
University of Cambridge
UK

Hiroshi Ohrui Yokohama
University of Pharmacy
Japan

Ting-Chao Chou
PD Science LLC
USA

Ronald Moss
Ansun Biopharma
USA

Chandrika Johnson
Fayetteville State University
USA

Anjali Joshi
Texas Tech University Health Sciences Center
USA

Aaron Berliner
Bio/Nano Research Group
USA

Girish J. Kotwal
UMass School of Medicine
USA

Luigi Santacroce
University of Bari
Italy

Mohammad Mir
Western University of Health Sciences
USA

Yolanda Revilla
Centro de BiologÃa Molecular â€œSevero Ochoaâ€
Spain

Mohammad Hossain
Kansas State University
USA

Jelena Prpic
Croatian Veterinary Institute
Croatia

Ilya B Tsyrlov
XENOTOX Inc
USA

Pedro Brandao dos Santos Pedrosa
Leibniz UniversitÃ¤t
Germany

Walter Doerfler
University of Erlangen-Nuernberg & Cologne University
Germany

Shen Kunling
Capital Medical University
China

Ibrahim M. Banat
University of Ulster
UK

ZhangLei
Chinese Academy of Agricultural Sciences
China

Angelika Krumina
Riga Stradins University
Latvia

Kunihiro Kaihatsu
Osaka University
Japan

Shubhada Bopegamage
Slovak Medical University
Slovakia

Raquel Rodrigues
Umea University
Sweden

Shahana Choudhury
Meharry Medical College
USA

Michael W
Washabaugh MedImmune
USA

Farshad Guirakhoo
GeoVax
USA

George Adigbli
University College London
UK

Brian L Pearlman
Atlanta Medical Center
USA

Chunyan Liu
Capital Medical University
China

Jiehao Cai
Childrenâ€™s Hospital of Fudan University
China

Todd E. Bell
Texas Tech University Health Science Center
USA

Marcin SieÅ„czyk
Wroclaw University of Technology
Poland

Filippo De Nicolellis
Fiumcello,Friuli Venezia Giulia
Italy

Paola Grandi
University of Pittsburgh
USA

Charles J. Russell
St.Jude Childrenâ€™s Research Hospital
USA

Ralph A. Tripp
Tripp University of Georgia
USA

Franco Lori
ViroStatics srl
Italy

Julia Hilliard
Georgia State University
USA

Polly Roy
London School of Hygiene and Tropical Medicine
UK

Mugdha Vasireddi
Georgia State University
USA

Louise Cosby
Queenâ€™s University
UK

Larry Kauvar
Trellis Bioscience
USA

Estanislao Nistal-VillÃ¡n
University of Navarra
Spain

Jagannadha Sastry
The University of Texas
USA

Chuanling Zhang
Peking University
China

Anton Sholukh
Texas Biomedical Research Institute
USA

Dimiter Dimitrov
NIH
USA

Suresh K. Mittal
Purdue University
USA

Ruth M. Ruprecht
Texas Biomedical Research Institute
USA

Marc H.V. Van Regenmortel
University of Strasbourg
France

Jose Esparza
Bill & Melinda Gates Foundation
USA

Kamaleldin B Said
Carleton University
Canada

Jorge C. Blanco
Sigmovir Biosystems Inc
USA

Jean-Marie Andrieu
University of Paris-Descartes
France

Ruma Mukerjee
Temple University
USA

Pedro BrandÃ£o dos Santos Pedrosa
Leibniz University of Hannover
Germany

Khaled Barakat
University of Alberta
Canada

Chil-Yong Kang
Western University
Canada

Olga S. Latinovic
University of Maryland
USA

Eckard Wimmer
Stony Brook University
USA

Francois Dufrasne
Universite Catholique de Louvain
Belgium

Patrick J Brennan
Colorado State University
USA

Natalia Tschowri
Humboldt-UniversitÃ¤t zu Berlin
Germany

Omar Rossi
University of Cambridge
UK

Amparo Gamero Lluna
University of Valencia
Spain

Amelie Mc Fadyen
University of Quebec in Montreal
Canada

Amin Fadl
University of Wisconsin-Madison
USA

Amy F.Savage
University of Florida
USA

Ayman Noreddin
Chapman University School of Pharmacy
USA

Carlos Alberto Guzman
Helmholtz Centre for Infection Research
Germany

Choong-Min Kang
California State University
USA

Darron R. Brown
Indiana University School of Medicine
USA

Edward J Woznaik
State Veterniarian and Lieutetnant Colonel
USA

Elisabeth Carniel
Institut Pasteur
France

Fernando de la Calle
PharmaMar
Spain

Friedrich Goetz
University TÃ¼bingen
Germany

Hua Zhu
Rutgers University
USA

Jizhong Zhou
University of Oklahoma
USA

Mahdi Saeed
Michigan State University
USA

Manfred Hochleithner
VÃ–K
Austria

John G Thomas
West Virginia University
USA

Kay Taylor
Founder/Ambassador Preventing Cervical Cancer (PINCC)
USA

Maria Athanassiou
OptiMAStem Cell Technologies
USA

Mark Enright
Manchester Metropolitan University
UK

Masataka
Tohoku University
Japan

Miklas Scholz
Civil Engineering Stanford University
UK

Mohannad AL-Saghir
Ohio University Zanesville
USA

Natascia Bruni
Candioli Pharma Organization
Italy

Peter Proksch
Institute of Pharmaceutical Biology and Biotechnology at the University of DÃ¼sseldorf
Germany

Piero Mastroeni
Infection and Immunity University of Cambridge
UK

Qiao Sun
Shanghai Pudong New Area Center for Disease Control and Prevention
China

Rajesh Sani
South Dakota School of Mines and Technology
USA

Rajinder S. Ranu
Colorado State University
USA

Schutzbank Ted
St.John Providence Health System, Michigan
USA

Teresa Norris
HPV Awareness Corporation/Corporation de Sensibilisation VPH
Canada

Thomas Kurz
Heinrich-Heine University DÃ¼sseldorf
Germany

Euro Virology 2020

On behalf of the Advisory Committee we take great pleasure in welcoming academic scientists, researchers, research scholars, students and experts of application fields for the 12th International Virology Summit to foster the advancement in the field by contributing with your expertise to what promises to be a very comprehensive and exciting meeting.

12th International Virology Summit (Euro Virology 2020), is a webcast going to be held during June 24-25, 2020. The Virology online conferences is attracting global participant’s intent on sharing, exchanging and exploring new avenues of Virology Research & Development. The event will have Plenary speakers, established Keynote speakers, young researchers presentations and poster presentations. In addition, there will be poster presentations along with workshops and special sessions would be interested in audience.

The aim of the Virology Webinar is to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists by bringing together the world class researchers, International Communities and Industrial heads to discuss the latest developments and innovations in the fields of Virology.

We sincerely hope that Euro Virology 2020 serves as an international platform for meeting researchers from around the world, widen professional contact and create new opportunities, including establishing new collaborations.

Why to attend?

With members from around the world focused on learning about Virology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Virology community. This event will provide an opportunity to build and expand your network with various people and gives chance to make collaboration with other universities and research labs. It also helps you to meet the experts in the relevant field of study. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new Virology developments, and receive name recognition at this 2-day event.

Top Associations and Societies of Virology:

Center for Emerging Viral Infections Research
Hunter Medical Research Institute
Center for Global Research and Intervention in Infectious Diseases
Infectious and Immunologic Diseases Research Center
Global virus network
HIV Medicine Association
International AIDS Society
Canadian Society for International Health

Target Audience:

Target audience for Virology Podcast 2020 Includes

The Virology Webcast welcomes all the eminent leaders and Professors of virology to share their research work and experiences, we are open for all the scientists from all over the globe with their new findings. We encourage young researchers, students to participate and share their ideas in the conference. We are also honor to welcome Directors, Vice President, Head of technology from industries, R&D Chemist, Life Sciences Specialist, and Exhibitors are also welcoming to exhibit their projects and products.

Who should attend?

Virologist
Microbiologist
Virology Students
Virology Researchers
Virology and Microbiology Faculty
Medical Colleges
Virology and Microbiology Associations and Societies
Research Labs
Manufacturing Medical Devices Companies
Deans and Professors
CEO / CSO / COO
CMO / Head of Scientific Affairs
Head of Virology
Medical Schools/Colleges
Nursing Schools/Colleges
Business Entrepreneurs
Strategic Alliance
Alliance/Partnership Development
VP of Microbiology

Top Associations and Societies of Virology:

Center for Emerging Viral Infections Research
Hunter Medical Research Institute
Center for Global Research and Intervention in Infectious Diseases
Global virus network
HIV Medicine Association
International AIDS Society

Young Researchers Forum - Young Scientist Awards Euro Virology 2020

Young Research’s Awards at Euro Virology 2020 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Euro Virology 2020 young research forum.

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Deadline for Registrations:

Platform for collaboration among young researchers for better development
Till April 28, 2020 – $325
Till May 28, 2020 – $425
Till June 21, 2020 – $525

Opportunities for Conference Attendees:

For Researchers & Faculty:

Speaker Presentations
Poster Display
Symposium hosting
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students & Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group Registrations

For Business Delegates:

Speaker Presentations
Audience participation
Symposium hosting
Book Launch event
Networking opportunities

For Companies:

Exhibitor and Vendor Booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Session-01: General Viro logy

Virology is the scientific discipline concerned with the study of the biology of viruses and viral diseases, including the distribution, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of viruses. Viruses also cause serious diseases in plants and livestock. Viruses have been implicated in a disease that is ravaging our honeybees, threatening natural pollination cycles and thus much of agriculture. A major branch of virology is virus classification. Viruses can be classified according to the host cell they infect animal viruses, plant viruses, fungal viruses, and bacteriophages. Viruses cause many important infectious diseases, among them the common cold, influenza, rabies, measles, many forms of diarrhea, hepatitis, Dengue fever, yellow fever, polio, smallpox and AIDS. Herpes simplex causes cold sores and genital herpes and is under investigation as a possible factor in Alzheimer's. The study of the manner in which viruses cause disease is viral pathogenesis. The degree to which a virus causes disease is its virulence.

Related Conferences:

18^th International Conference on Pharmaceutical Microbiology and Biotechnology, February 24-25, 2020, Berlin, Germany | 38^th Euro Global Summit and Expo on Vaccines & Vaccination Webinar, June 08-09, 2020 | 49^th World Congress on Microbiology Webcast, June 15-16, 2020 | 15^th International Conference on Microbial Interactions & Microbial Ecology, August 17-18, 2020, Paris, France | 8^th World Congress and Expo on Applied Microbiology, September 28-29, 2020, Barcelona, Spain

Related Societies & Associations:

Europe: German Society for Virology, International Society for Antiviral Research, International Union of Microbiological Societies, Society for General Microbiology, European Society for Veterinary Virology, Dutch Society for Medical Microbiology, European Society of Clinical Microbiology and Infectious Diseases, Federation of European Microbiological Societies (FEMS).

Asia-Pacific: International Society for Applied Phycology; International Union of Microbiological Societies; Microscopy Society (Singapore), Singapore National Academy of Sciences; Japanese Society of Microbial Ecology, Asia Pacific Society for Marine Biotechnology; Committee of Asia Pacific Electron Microscopy Societies; Federation of Asia Pacific Microbiological Societies.

U.S.A: IUMS International Union of microbiological societies, Southern California Branch of the American Society for Microbiology (SCASM), American society for microbiology, SIMB-Society for industrial Microbiology and biotechnology, SFAM-Society for Applied Microbiology-London, Society for industrial microbiology.

Session-02: Molecular and Cellular Virology

Viral evolution is a subfield of evolutionary biology and virology that is specifically concerned with the evolution of viruses. Many viruses, in particular RNA viruses, have short generation times and relatively high mutation rates (on the order of one point mutation or more per genome per round of replication for RNA viruses). Virus Genomes are very small and they are incredibly diverse and subject to rapid genetic change.

Related Conferences:

Related Societies & Associations:

Session-03: Animal Virology

Viruses are smaller and simpler in construction than unicellular microorganisms, and they contain only one type of nucleic acid—either DNA or RNA—never both. As viruses have no ribosomes, mitochondria, or other organelles, they are completely dependent on their cellular hosts for energy production and protein synthesis. They replicate only within cells of the host that they infect. Animal virology developed largely from the need to control viral diseases in humans and their domesticated animals. Viruses, like other infectious agents, enter the animal body through one of its surfaces. They then spread either locally on one of the body surfaces or through lymphatic and blood vessels to produce systemic infection. Iridoviridae and African Swine Fever Virus, adenovirus, Papillomavirus and Polyomavirus, herpesvirus are some of the major viruses causing diseases in cattle. At least one major disease of each domestic animal species except sheep is caused by a herpesvirus, including such important diseases as infectious bovine rhinotracheitis, pseudorabies, and Marek's disease. However, there are several approaches to their prevention, control, and eradication. The most generally useful control measure is the use of vaccines.

Related Conferences:

Related Societies & Associations:

Session-04: Clinical and Diagnostic Virology

Diagnosis of any probable viral infection with the help of various tests such as, specific, assorted or conventional tests to identify the causative virus. Multiple methods are in use for laboratory diagnosis in probing the viral infections, including serology, viral culture, antigen detection, and nucleic acid detection. Due to various developments in the technology, we see high-end and quite impressive immunologic and molecular diagnostic tests are developed to provide more accurate results and to detect the viruses- type, number and to identify their pathogenicity as well. This field provides specific recommendations for diagnostic approach to clinically important viral infections.

Related Conferences:

Related Societies & Associations:

Session-05: Viral Immunology

Viral immunology is simply the study of immune responses to viruses. A prolonged tissue-damaging effect resulting from an immune reaction against viruses is considered immunopathology. Such situations most commonly involve persistent viruses, which are themselves often mildly cytodestructive in the absence of an immune reaction. Chronic tissue damage initiated by viruses can also result in development of an auto reactive and an occasionally oncogenic response

Related Conferences:

Related Societies & Associations:

Session-06: Anti-Retroviral Therapy

Antiretroviral therapy refers to HIV treatment that uses a combination of two or more antiretroviral drugs. Antiretroviral therapy revolutionized HIV treatment upon its introduction in 1996. Antiretroviral therapy is an effective treatment for HIV. It does not cure the condition, but it can reduce the viral load to undetectable levels. This means that the virus is not transmittable through sexual activity and a person's immune system can recover. It usually takes around 3–6 months for the viral load to reach undetectable levels.

Related Conferences:

Related Societies & Associations:

Session-07: Pediatric Viral Infectious Diseases

Infections caused by viruses are universal during childhood and adolescence. Clinicians will regularly care for children and adolescents who present with infections caused by a wide number of viral pathogens. These infections have varied presentations. Many infections may have clinical presentations that are specific to the infecting virus but present differently, based on the age and immunocompetence of the patient. Some children are directly impacted early in their lives when maternal disease results in an in utero infection (cytomegalovirus, rubella virus, or parvovirus B19). Other viruses may infect children in a predictable pattern as they grow older (rhinovirus or influenza virus).

Related Conferences:

Related Societies & Associations:

Session-08: Antiviral Drug Discovery and Development

Viruses are intracellular pathogens that have evolved many devious strategies to evade host immune responses and, as a consequence, have plagued human health throughout history. Combating viral diseases with vaccines or antiviral drugs, or both, is a constant challenge. Even when successful strategies are discovered and employed, the high rate of genetic change exhibited by many viruses, particularly RNA viruses, often enables drug resistance or vaccine escape. This is compounded by the periodic emergence of new viral pathogens.

Related Conferences:

Related Societies & Associations:

Session-09: Viral Vaccines

Vaccines have been among the most effective health approach for protecting the individual against viral disease, with two of worlds successful vaccine being against small pox and poliovirus. Viral vaccines is a combination of inactivated viruses and activated viruses. Inactivated or killed viral vaccines contain viruses, they do not have ability to replicate and to bring about a response it contains an antigen. Activated or livevaccines contain the live form of the virus. Currently, Virus like particles organizes a new vaccine concept. Such particles consist of self-assembled structural proteins from the virus which can elicit an immune response but as they lack the genetic material from the virus are safer vaccines, research going on the rational development of a triple-layered virus like particle vaccine against rotavirus using the baculovirus insect cell system as production platform.

Related Conferences:

Related Societies & Associations:

Session-10: Plant and Agricultural Virology

The epidemiology of plant virus diseases concerns the cyclical development of virus diseases within plant populations in time and space. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects a wide range of plants, especially tobacco and other members of the family Solanaceae. In the viral life cycle, viral entry is the emergent stage of infection, as the virus invades with the host cell and intrudes viral material into the cell.

Related Conferences:

Related Societies & Associations:

Session-11: Viral Oncology

Viral oncology is a subdivision of oncology,in these it is concerned with treatment of human cancers /tumors with virus particles. Approximately 20% of all cancers worldwide results from chronic infections, in specific, up to 15% of human cancers is characterized by a viral aetiology with higher incidence in Developing Countries. Certainly, the infectious nature of specific tumors has important implications in their prevention, diagnosis, and therapy. In the 21st Century, the research on viral oncology field continues to be dynamic, with new significant and original studies on viral oncogenesis and as a translational research from virology for the treatment of cancer.

Related Conferences:

Related Societies & Associations:

Session-12: STD & HIV/ AIDS and Emerging Viral Diseases

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the predominant way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

Related Conferences:

Related Societies & Associations:

Session-13: Respiratory viral diseases

Recently one of the most common viral infections are the respiratory tract infections. Respiratory tract infections are including with the infection of sinuses, throat, airways or lungs. The respiratory tract infections (RTI) are generally classified in tow subdivisions as Upper Respiratory tract infections(URTI) and Lower Respiratory tract infections (LRTI). The viruses which are associated with respiratory disorders these are adenovirus, parainfluenza virus, respiratory syncytial virus, coronavirus, Coxsackie virus, human metapneumovirus.

Related Conferences:

Related Societies & Associations:

Session-14: Gastrointestinal viral diseases

Viral gastroenteritis is an intestinal infection marked by watery diarrhea, abdominal cramps, nausea or vomiting, and sometimes fever. The most common way to develop viral gastroenteritis — often called stomach flu —is through contact with an infected person or by ingesting contaminated food or water. If you're otherwise healthy, you'll likely recover without complications. But for infants, older adults and people with compromised immune systems, viral gastroenteritis can be deadly. There's no effective treatment for viral gastroenteritis, so prevention is key. In addition to avoiding food and water that may be contaminated, thorough and frequent hand-washings are your best defense.

Related Conferences:

Related Societies & Associations:

Session-15: Hepatic viral diseases

Hepatitis means inflammation of the liver. Many illnesses and conditions can cause inflammation of the liver, for example, drugs, alcohol, chemicals, and autoimmune diseases. Many viruses, for example, the virus causing mononucleosis and the cytomegalovirus, can inflame the liver. Most viruses, however, do not attack primarily the liver; the liver is just one of several organs that the viruses affect. There are several hepatitis viruses; they have been named types A, B, C, D, E, F (not confirmed), and G. The most common hepatitis viruses are types A, B, and C. Reference to the hepatitis viruses often occurs in an abbreviated form (for example, HAV, HBV, HCV represent hepatitis viruses A, B, and C, respectively.)

Related Conferences:

Related Societies & Associations:

Session-16: Neurologic viral diseases:

Neurological viral diseases are the most important field that signifies the connection of clinical neuroscience, virology, immunology, and molecular biology. The main target of this field is to investigate the viruses which can infect the nervous system. Without this there is a additional study of this division, the use of some viruses to trace neuroanatomical pathways, for gene therapy, and to eliminate detrimental populations of neural cells.

Related Conferences:

Related Societies & Associations:

Session-17: Insect vector and virus epidemiology

Currently, molecular studies on replication, assembly, and host interactions of insect viruses have contributed enormously to molecular, cellular, organismal biology. The ease with which many insect viruses are propagated in cell cultures or live animals, the high yields virus particles or virus encoded macromolecules and the simplicity with which many insect viruses can be genetically manipulated represent just a few experimental advantages provided by these pathogens.

Viral epidemiology is concerned with study of incidence and spread of viruses in population over time. Host, virus and environmental factors are monitored to determine the dynamics of viral infections, the ultimate goal of which is to devise intervention strategies.

Related Conferences:

Related Societies & Associations:

Session-18: Bacterial and Fungal Virology

The study of parasites that multiply inside bacteria by making use of the host biosynthetic machinery is known as bacterial virology. Bacteriophages are the viruses that infect and replicate in bacteria. Since the early 1970s, bacteria have continued to develop resistance to antibiotics such as penicillin, and this has led to a renewed interest in the use of bacteriophages to treat serious infections.

It deals with viruses that infect fungi are known as Mycoviruses. Mycoviruses have double-stranded RNA genomes and isometric particles, but about 30% of them have positive sense and single-stranded RNA genomes, to be a true Mycoviruses, they must have an ability to be transmitted ( in other words be able to infect other healthy fungi).

Related Conferences:

Related Societies & Associations:

Session-19: Current Focus in Virology Research

Current research in virology includes the investigation of mechanism of HIV replication and pathogenesis. Other research involves chronic and latent infections caused by viruses such as Epstein-Barr and Kaposi's sarcoma associated herpes virus and herpes simplex and the retrovirus. Scientists are also studying viral host interactions along with the mechanism of viral induced cellular transformation. Drug-drug interactions happen when a drug interacts, or meddles, with another drug. Change the way either of the drug demonstration in the body, or cause sudden reactions. The drug included can be doctor prescribed solutions, over-the-counter meds and even vitamins and normal items.

Related Conferences:

Related Societies & Associations:

Session-20: Microbiology

Pure Microbiology provides a broad platform of a large plethora of research and plenty of new insights into different areas of Microbiology.

Different branches of Microbiology include mycology, Virology, Immunology, infectious diseases, bacteriology, nematology, parasitology, etc., the antibiotics are the agents used against pathogenic bacteria, either orally or paternally.

Related Conferences:

Related Societies & Associations:

Top Virology and Microbiology Universities Worldwide:

USA Universities:

The University of Pittsburgh, Vanderbilt University, University in New York City, The University of Texas, University of California, University School of Medicine, University of the Pacific, The University of Washington, Emory University, The University of Southern California, The Boston University, Case Western Reserve University, University in Chicago, Health Sciences University, Columbia University, University in Los Angeles, The University of Alabama, Saint Louis University, The University of Colorado, The Ohio State University, Nova South-eastern University, The University of North Carolina, Cornell University, Stanford University, University of Iowa, Texas Tech University System, University in Sacramento, The University of Nebraska , The University of Florida, University of Minnesota, Georgetown University, Brown University, The Rowan University, East Carolina University, Pennsylvania University.

Europe Universities:

University College London, University of Bristol, University of Silesia, Wroclaw Medical University, Bogomolets National Medical University, University of Zagreb, University of Cambridge, University of Sussex, University of Edinburgh, Kings College London, University of Brighton, Plymouth University, University of Exeter, Swansea University, University of Oxford, Swiss Federal Institute of Technology, University of Brighton, Ecole Polytechnique Federal de Lausanne

Asia Pacific and Middle East Universities:

Virology Societies & Associations:

In U.S.A:

American society for microbiology, SIMB-Society for industrial Microbiology and biotechnology, SFAM-Society for Applied Microbiology-London, Society for industrial microbiology, IUMS International Union of microbiological societies, Southern California Branch of the American Society for Microbiology (SCASM)

In Europe:

European Society for Veterinary Virology, Dutch Society for Medical Microbiology, European Society of Clinical Microbiology and Infectious Diseases, Federation of European Microbiological Societies (FEMS), German Society for Virology, International Society for Antiviral Research, International Union of Microbiological Societies, Society for General Microbiology.

In Asia-Pacific:

Asia Pacific Society for Marine Biotechnology; Committee of Asia Pacific Electron Microscopy Societies; Federation of Asia Pacific Microbiological Societies; International Society for Applied Phycology; International Union of Microbiological Societies; Microscopy Society (Singapore), Singapore National Academy of Sciences; Japanese Society of Microbial Ecology.

Virology Journals:

Acta Virologica, Acta Tropica, AIDS Book Review Journal, AIDS Patient Care and STDs, AIDS Research and Human Retroviruses, American Journal of Public Health, American Society for Microbiology News, Annals of Internal Medicine, Antimicrobial Agents and Chemotherapy, Antimicrobics and Infectious Diseases Newsletter, Apoptosis, Applied and Environmental Microbiology, Applied Biochemistry and Microbiology, Archives of Virology, BBA - Biochimica et Biophysica Acta, BBA - Molecular Basis of Disease - Online Version, British Medical Journal – BMJ, Canadian Journal of Microbiology, Cell, Clinical Care Options for HIV, Clinical Microbiology Newsletter, Clinical Microbiology Reviews, Current Biology, Current Microbiology, Diagnostic Microbiology and Infectious Disease, Enzyme and Microbial Technology, FEMS Immunology and Medical Microbiology, FEMS Microbiology, International Journal of Antimicrobial Agents, International Journal of HIV & AIDS, Journal of AIDS/HIV, Journal of Antimicrobial Chemotherapy, Journal of Bacteriology, Journal of Clinical Virology, Journal of General Virology, Journal of Medical Virology, The Lancet, Microbiology, Nature, New England Journal of Medicine.

Online Virology Conferences advisory board invites all the participants across the world to attend “12^th International virology summit” going to be held during June 24-25, 2020 .The Theme of the conference is "An outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in Worldwide in the aspect of Virology" will explore the advances in Virology.

Market Analysis:

The global virology market is estimated in 2017 at $1693 million and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is one of the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. North America is expected to retain the top market position over this forecast period.

Globally the Europe is projected to maintain the position as the second largest market. Throughout the forecast period, Europe is estimated to record the highest CAGR, recognized by enhanced healthcare infrastructure, growing affordability of diagnostic tests for viral diseases and facilitated access to diagnostics.

The global viral inactivation market size was valued in 2016 at USD 1.8 billion and is expected to witness a CAGR of 12.5% during these forecast period. The Industrial Analysis of Virology in between 2016-2022 as shown below

Key Players in the Global Virology Market

The famous players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Boehringer Ingelheim Corporation, Merck and Co. Inc., Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. in phase 2 has several drug candidates, including diabetes, cardiac arrest, cancer, and hepatitis C, and in phase 3 some candidates, including breast cancer, Alzheimer's, Ebola, and HIV and also has many other candidates, which are currently under review.

Abivax, one of the high profile biotech companies in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and Ebola, currently under development.

Virology Market: Segmentation

The Virology Market stands segmented By Product Type into Diagnosing Test like DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests.

On the basis of diagnosis tests, hepatitis B, Hepatitis C, HIV, Human papillomavirus (HPV), and other tests (like influenza, Ebola, and dengue) are estimated to hold the largest market share globally during the forecast period. Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, Immunomodulators), Interferon’s (Cytokines) are some of the Viral Infection controlling Methods. Immunoprophylaxis therapy and antiviral drugs are the fastest growing market segments in these estimated forecast period.

Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract & Urinary Tract infections, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections. In the global virology market STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application types. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, and Pharmacies.

Importance & Scope:

Virology is the study of viruses. It is important to study viruses because it will allow us to understand the different mechanisms that viruses use to replicate inside a cell, and therefore, we can target those mechanisms without causing high toxicity to the infected organism.

The fields of virology and genomic research have been closely linked for many years; the first whole genome to be sequenced was viral in origin – bacteriophage phi X174, in 1977. As then, many more viral genomes have been mapped, and with the human genome also available, it is now possible to determine viral–host interactions during infection. This has been consequently provided a complete record of potential antiviral targets to be researched. A dramatic increase in research in the field of rational drug design is due to the advent of the HIV pandemic led, resulting in the large number of antiviral drugs and vaccines arriving clinical trials today.

A virologist is specialized who studies the growth, development, structure and characteristics of different viruses. They isolates and makes cultures of significant viruses in a standard inhibitory medium, controlling certain factors, like, aeration, moisture, temperature, and nutrition, etc.

Far of the research here involves using animal studies, and also use information from host and viral genomes to conclude viral virulence. Plant virology is a branch of study of viruses and how they affect plants. These infections can have a terrible impact on agriculture in developing nations.

Until recently, the only microbiota that we could identify in a complex community (e.g., gut flora or seawater) was those we could cultivate. In the 21st century the research will allow the identification of new families of organisms (including viruses) by high-speed sequencing of RNA and DNA. An example of “deep sequencing” technology of mixed populations were found in respiratory secretions and gastrointestinal contents is revealing novel virus families, together pathogenic and nonpathogenic.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 24-25, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View